Mortality and complications of scrub typhus in the paediatric population: a systematic review and meta-analysis

Kaushik Mukhopadhyay1, Samir Chakrabarty2, Chandan Chatterjee1

  • 1Pharmacology, ESIC PGIMSR & ESIC Medical College, Diamond Harbour Road, Joka, Kolkata 700104, West Bengal, India.

Insights

Scrub typhus in children has a 1.1% case fatality rate, with mortality declining recently. Hepatitis, shock, and pneumonia are common complications, while multi-organ dysfunction drives mortality.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public health

Background:

  • Scrub typhus is a significant cause of treatable febrile illness in children, often leading to severe complications and mortality.
  • Despite its impact, comprehensive data on pediatric scrub typhus case fatality and complication patterns are limited.

Purpose of the Study:

  • To systematically review and estimate the case fatality risk (CFR) of scrub typhus in children.
  • To analyze the common complications and their impact on mortality in pediatric scrub typhus cases.

Main Methods:

  • Systematic review of original articles published between 1990 and 2020.
  • Pooled prevalence calculation using a random effects model (restricted maximum likelihood method) with R statistical software.
  • Reporting of pooled case fatality rate and its 95% confidence intervals (CIs).

Main Results:

  • Thirty-seven articles involving 3329 children were included. The overall CFR was 1.1% (95% CI 0.05 to 2%).
  • A declining mortality trend was observed over the last five years.
  • Hepatitis (30.68%), pneumonia (14.71%), acute kidney injury (13.72%), and shock (14.45%) were the most frequent complications. Multi-organ dysfunction syndrome significantly contributed to mortality.

Conclusions:

  • Scrub typhus presents a substantial but treatable risk to children, with a low overall CFR but significant complication burden.
  • Hepatitis and pneumonia are prevalent complications, and multi-organ dysfunction syndrome is a key driver of mortality.
  • The declining mortality trend suggests potential improvements in management or earlier diagnosis, warranting continued surveillance.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
37
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
46
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
525